The effect of sodium‐glucose cotransporter 2 inhibitors on <scp>HbA1c</scp> variability and cardiovascular and renal adverse outcome in patients with <scp>T2DM</scp>

In patients with high HbA1c variability, SGLT2 inhibitor initiation was associated with superior effectiveness in reducing HbA1c variability compared to DPP-4 inhibitors. The initiation of SGLT2 inhibitors versus DPP-4 inhibitors was linked to significantly reduced cardiovascular and renal adverse events.

Authors

Institutions

Publication Details

Journal
Diabetes Obesity and Metabolism
Published
2025-06-13
DOI
https://doi.org/10.1111/dom.16509
Citations
3
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
3.88

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The effect of sodium‐glucose cotransporter 2 inhibitors on HbA1c variability and cardiovascular and renal adverse outcome in patients with T2DM

Christopher Tze‐Wei Tsang, Ran Guo, Mei‐Zhen Wu, J.-R. Zhang et al.
3 citations
Diabetes Obesity and Metabolism
Diabetes Treatment and Management
3.88
article

The effect of sodium‐glucose cotransporter 2 inhibitors on HbA1c variability and cardiovascular and renal adverse outcome in patients with T2DM

Christopher Tze‐Wei Tsang, Ran Guo, Mei‐Zhen Wu, J.-R. Zhang, Haochen Xuan, Yingxian Liu, Q W Ren, Wouter Ouwerkerk, Chanchal Chandramouli, Carolyn S.P. Lam, Jasper Tromp, Wenli Gu, Tiew‐Hwa Katherine Teng, Jiayi Huang, Anping Cai, Kai‐Hang Yiu, Yik‐Ming Hung, Ambarish Pandey, Ching‐Yan Zhu
article en
3 citations

Abstract

In patients with high HbA1c variability, SGLT2 inhibitor initiation was associated with superior effectiveness in reducing HbA1c variability compared to DPP-4 inhibitors. The initiation of SGLT2 inhibitors versus DPP-4 inhibitors was linked to significantly reduced cardiovascular and renal adverse events.

Diabetes Obesity and MetabolismVol. 27(9)
University Medical Center Groningen (NL), National University of Singapore (SG), University of Groningen (NL), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Queen Mary Hospital (CN), Peking Union Medical College Hospital (CN), Baim Institute for Clinical Research (US), Guangzhou First People's Hospital (CN), University of Hong Kong - Shenzhen Hospital (CN), Guangdong Academy of Medical Sciences (CN), National Heart Centre Singapore (SG), National University Health System (SG), Amsterdam University Medical Centers (NL), Guangdong Provincial People's Hospital (CN), Southern Medical University (CN), The University of Texas Southwestern Medical Center (US), University of Amsterdam (NL), University of Hong Kong (HK), South China University of Technology (CN), Guangzhou Medical University (CN)
National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, Hospital Authority, Sanming Project of Medicine in Shenzhen
Good health and well-being
Openalex Percentile: Top 6%
Diabetes Treatment and Management
3.88
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.